Loading...
Preclinical development of BCG.HIVA(2auxo.int), harboring an integrative expression vector, for a HIV-TB Pediatric vaccine. Enhancement of stability and specific HIV-1 T-cell immunity
One of the critical issues that should be addressed in the development of a BCG-based HIV vaccine is genetic plasmid stability. Therefore, to address this issue we have considered using integrative vectors and the auxotrophic mutant of BCG complemented with a plasmid carrying a wild-type complementi...
Na minha lista:
| Udgivet i: | Hum Vaccin Immunother |
|---|---|
| Main Authors: | , , , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
Taylor & Francis
2017
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5557246/ https://ncbi.nlm.nih.gov/pubmed/28426273 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/21645515.2017.1316911 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|